
Kezar Life Sciences, Inc. (NASDAQ:KZR) announced regulatory updates and began exploring strategic alternatives.
The company has retained TD Cowen to support it with the strategic review process.

Kezar Life Sciences, Inc. (NASDAQ:KZR) announced regulatory updates and began exploring strategic alternatives.
The company has retained TD Cowen to support it with the strategic review process.